Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.320 Biomarker disease PSYGENET Xenobiotic metabolizing and transporter genes: gene-gene interactions in schizophrenia and related disorders. 21142916 2010
CUI: C0012833
Disease: Dizziness
Dizziness
0.010 Biomarker phenotype BEFREE Women and CYP3A5*1/*1 subjects showed more often dizziness (p = 0.034; p = 0.009). 29325225 2018
CUI: C0042571
Disease: Vertigo
Vertigo
0.010 Biomarker phenotype BEFREE Women and CYP3A5*1/*1 subjects showed more often dizziness (p = 0.034; p = 0.009). 29325225 2018
CUI: C0442874
Disease: Neuropathy
Neuropathy
0.030 Biomarker group BEFREE We test the hypothesis that CYP3A5 expressers experience less vincristine neuropathy than do CYP3A5 non-expressers. 21225912 2011
CUI: C0242379
Disease: Malignant neoplasm of lung
Malignant neoplasm of lung
0.100 GeneticVariation disease BEFREE We suggest that CYP3A5*1 may play an important role in individual predisposition to lung cancer in Taiwan. 12822676 2003
CUI: C0684249
Disease: Carcinoma of lung
Carcinoma of lung
0.100 GeneticVariation disease BEFREE We suggest that CYP3A5*1 may play an important role in individual predisposition to lung cancer in Taiwan. 12822676 2003
CUI: C1306460
Disease: Primary malignant neoplasm of lung
Primary malignant neoplasm of lung
0.100 GeneticVariation disease BEFREE We suggest that CYP3A5*1 may play an important role in individual predisposition to lung cancer in Taiwan. 12822676 2003
CUI: C0020538
Disease: Hypertensive disease
Hypertensive disease
0.100 GeneticVariation group LHGDN We speculate whether a high CYP3A5 expressor allele frequency among African-Americans may contribute to a high prevalence of sodium-sensitive hypertension in this population. 12754175 2003
CUI: C0151650
Disease: Renal fibrosis
Renal fibrosis
0.010 GeneticVariation disease BEFREE We investigated whether genetic polymorphisms affecting CYP3A5 and ABCB1 influence EMT and kidney fibrosis. 25521359 2014
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.020 GeneticVariation disease BEFREE We investigated the prevalence of common polymorphisms that have been associated with diseases, such as atherosclerosis (ALOX5), hypertension (CYP3A5, AGT, GNB3), diabetes (CAPN10, TCF7L2, PTPN22), prostate cancer (DG8S737, rs1447295), Hirschsprung disease (RET), and age-related macular degeneration (CFH, LOC387715). 18248681 2008
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.010 GeneticVariation disease BEFREE We investigated the prevalence of common polymorphisms that have been associated with diseases, such as atherosclerosis (ALOX5), hypertension (CYP3A5, AGT, GNB3), diabetes (CAPN10, TCF7L2, PTPN22), prostate cancer (DG8S737, rs1447295), Hirschsprung disease (RET), and age-related macular degeneration (CFH, LOC387715). 18248681 2008
CUI: C0020443
Disease: Hypercholesterolemia
Hypercholesterolemia
0.040 GeneticVariation disease BEFREE We investigated the effect of four polymorphisms in CYP3A4, CYP3A5 and ABCB1 genes on response to atorvastatin and CYP3A4 activity in Chilean subjects with HC. 22120734 2012
CUI: C0009324
Disease: Ulcerative Colitis
Ulcerative Colitis
0.040 GeneticVariation disease BEFREE We investigated the correlation between CYP3A5 genetic polymorphisms and the adverse events in patients with UC. 27717793 2017
CUI: C0023473
Disease: Myeloid Leukemia, Chronic
Myeloid Leukemia, Chronic
0.070 GeneticVariation disease BEFREE We investigated SLCO1B3 (T334G) and CYP3A5*3 polymorphisms by Polymerase Chain Reaction-restriction fragment length polymorphism in 86 Philadelphia positive newly diagnosed Egyptian CML patients (78 patients in chronic phase and 8 patients in accelerated phase). 23394475 2013
CUI: C0023449
Disease: Acute lymphocytic leukemia
Acute lymphocytic leukemia
0.080 GeneticVariation disease BEFREE We genotyped eight common single-nucleotide polymorphisms (SNPs) in the CYP3A4 and CYP3A5 genes in 511 children with ALL and investigated whether they influenced the survival of the patients. 25266680 2015
Childhood Acute Lymphoblastic Leukemia
0.080 GeneticVariation disease BEFREE We genotyped eight common single-nucleotide polymorphisms (SNPs) in the CYP3A4 and CYP3A5 genes in 511 children with ALL and investigated whether they influenced the survival of the patients. 25266680 2015
CUI: C0751606
Disease: Adult Acute Lymphocytic Leukemia
Adult Acute Lymphocytic Leukemia
0.060 GeneticVariation disease BEFREE We genotyped eight common single-nucleotide polymorphisms (SNPs) in the CYP3A4 and CYP3A5 genes in 511 children with ALL and investigated whether they influenced the survival of the patients. 25266680 2015
CUI: C0376358
Disease: Malignant neoplasm of prostate
Malignant neoplasm of prostate
0.390 AlteredExpression disease BEFREE We further showed androgen induction of CYP3A5 messenger RNA (mRNA) in LNCaP prostate cancer cell line. 17116727 2007
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.090 AlteredExpression disease BEFREE We further showed androgen induction of CYP3A5 messenger RNA (mRNA) in LNCaP prostate cancer cell line. 17116727 2007
CUI: C0242379
Disease: Malignant neoplasm of lung
Malignant neoplasm of lung
0.100 AlteredExpression disease BEFREE We found very low aryl hydrocarbon hydroxylase activity (19 per cent of normal) in about half the patients with lung cancer. 876325 1977
CUI: C0684249
Disease: Carcinoma of lung
Carcinoma of lung
0.100 AlteredExpression disease BEFREE We found very low aryl hydrocarbon hydroxylase activity (19 per cent of normal) in about half the patients with lung cancer. 876325 1977
CUI: C1306460
Disease: Primary malignant neoplasm of lung
Primary malignant neoplasm of lung
0.100 AlteredExpression disease BEFREE We found very low aryl hydrocarbon hydroxylase activity (19 per cent of normal) in about half the patients with lung cancer. 876325 1977
CUI: C0023530
Disease: Leukopenia
Leukopenia
0.060 GeneticVariation disease BEFREE We found that patients carrying the CYP3A5*1/*3 genotype demonstrated more side effects of fever, pleural effusion, and febrile neutropenia than those with the CYP3A5*3/*3 genotype (p = 0.075, 0.077, and 0.030, respectively); moreover, patients with the ABCB1 2677G/G genotype also showed more side effects of fever and febrile neutropenia than those with other genotypes (p = 0.024 and 0.027), In regard to ABCB1 3435C>T, patients with ABCB1 3435C/C tended to suffer leucopenia (p = 0.057). 19332043 2009
CUI: C0746883
Disease: Febrile Neutropenia
Febrile Neutropenia
0.010 GeneticVariation disease BEFREE We found that patients carrying the CYP3A5*1/*3 genotype demonstrated more side effects of fever, pleural effusion, and febrile neutropenia than those with the CYP3A5*3/*3 genotype (p = 0.075, 0.077, and 0.030, respectively); moreover, patients with the ABCB1 2677G/G genotype also showed more side effects of fever and febrile neutropenia than those with other genotypes (p = 0.024 and 0.027), In regard to ABCB1 3435C>T, patients with ABCB1 3435C/C tended to suffer leucopenia (p = 0.057). 19332043 2009
CUI: C0015967
Disease: Fever
Fever
0.010 GeneticVariation phenotype BEFREE We found that patients carrying the CYP3A5*1/*3 genotype demonstrated more side effects of fever, pleural effusion, and febrile neutropenia than those with the CYP3A5*3/*3 genotype (p = 0.075, 0.077, and 0.030, respectively); moreover, patients with the ABCB1 2677G/G genotype also showed more side effects of fever and febrile neutropenia than those with other genotypes (p = 0.024 and 0.027), In regard to ABCB1 3435C>T, patients with ABCB1 3435C/C tended to suffer leucopenia (p = 0.057). 19332043 2009